ABIONYX PHARMA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.146 EUR | -1.72% |
|
+2.46% | -36.40% |
| 03-14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| 03-11 | Abionyx: reduced net loss in 2023 | CF |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 03/06/2024 | 04/06/2024 | 05/06/2024 | 06/06/2024 | 07/06/2024 | |
|---|---|---|---|---|---|
| Last | 1.196 € | 1.188 € | 1.176 € | 1.166 € | 1.146 € |
| Change | +2.57% | -0.67% | -1.01% | -0.85% | -1.72% |
Performance
| 1 day | +3.26% | ||
| Current month | +8.11% | ||
| 3 months | +20.63% | ||
| 6 months | +10.19% | ||
| Current year | -36.40% | ||
| 1 year | +10.19% | ||
| 3 years | -9.48% | ||
| 5 years | +222.36% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Record volume 1
49 738
Record volume 2
49 738
Record volume 3
30 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
40 106 865
Capitalization (USD)
43 383 997
Net sales (EUR)
4 600 000
Net sales (USD)
4 975 866
Number of employees
61
Sales / Employee (EUR)
75 410
Sales / Employee (USD)
81 572
Free-Float
68.01 %
Free-Float capitalization (EUR)
27 492 889
Free-Float capitalization (USD)
29 739 332
Highs and lows
Current year
0.95
1.20
1 year
0.951.20
3 years
0.893.24
5 years
0.183.24
10 years
0.183.24
Indicators
Moving average 5 days
1.18
Moving average 20 days
1.12
Moving average 50 days
1.05
Moving average 100 days
1.07
Price spread / (MMA5)
+2.83%
Price spread / (MMA20)
-2.54%
Price spread / (MMA50)
-8.51%
Price spread / (MMA100)
-6.46%
RSI 9 days
61.74
RSI 14 days
61.49
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.72% | +2.46% | -36.40% | +10.19% | 43.38M | ||
| -0.27% | +6.15% | +18.79% | +48.88% | 125B | ||
| -0.15% | +1.70% | +13.49% | +34.95% | 108B | ||
| -1.16% | -0.25% | -4.92% | -8.28% | 24.57B | ||
| +0.57% | +4.14% | +3.29% | -3.90% | 22.82B | ||
| -0.72% | -1.01% | -11.02% | -28.72% | 18.19B | ||
| -0.75% | +1.53% | -41.48% | -33.93% | 16.54B | ||
| +0.48% | +6.26% | -12.30% | -29.51% | 16.5B | ||
| +1.69% | -0.55% | +2.20% | +44.48% | 13.39B | ||
| +2.53% | -9.25% | +22.21% | -7.86% | 11.1B | ||
| -0.57% | +3.42% | +83.72% | +187.84% | 9.22B | ||
| -1.31% | +15.12% | -23.45% | -32.46% | 8.49B | ||
| -0.08% | +2.27% | +9.70% | +52.84% | 7.94B | ||
| -0.46% | +1.98% | +14.11% | +39.82% | 7.89B | ||
| +0.88% | -0.29% | -4.20% | +24.60% | 7.34B | ||
| -0.61% | +15.99% | +38.99% | +47.96% | 6.55B | ||
| Average | +0.20% | +3.03% | +4.55% | +21.68% | ||
| Weighted average by Cap. | -0.13% | +4.70% | +9.74% | +27.80% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -41.18% | ||
| 2023 | -6.34% | ||
| 2022 | -17.78% | ||
| 2021 | +149.47% | ||
| 2020 | +213.19% | ||
| 2019 | -40.22% | ||
| 2018 | -72.95% | ||
| 2017 | -36.14% |
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- Quotes ABIONYX Pharma